The DOI matches its Crossref record; 31 of the 32 references it cites were found in a registry or an index.
Transient N-methyl-D-aspartate receptor blockade in early development causes lasting cognitive deficits relevant to schizophrenia
Abstract
Background Aberrant N-methyl-D-aspartate (NMDA) receptor-mediated glutamatergic transmission has been implicated in schizophrenia. We studied whether transient inhibition of NMDA receptor activity during early postnatal development would produce a behavioral phenotype resembling that of individuals who are susceptible to develop schizophrenia.Methods Rat pups were given injections of the NMDA channel blocker MK801 on postnatal days 7 through 10. This period is akin to the prenatal second trimester of primate development. Cognitive function was tested in adulthood.Results Treatment with MK801 impaired cognitive flexibility and working memory. The impairment in cognitive flexibility was due to increased perseverative behavior. Treatment did not affect locomotor activity or recognition memory.Conclusions These results suggest that a brief disruption of NMDA receptors during a sensitive period of cortical development is sufficient to produce selective cognitive deficits that are relevant to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A milder antagonism regime caused long-lasting behavioural changes and a specific longlasting decrease in cortical PVI numbers 29 , mimicking a key pathological feature of schizophrenia 2 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [29]
In the citing paper
“NMDAR antagonism likely induces a hyperglutamatergic state by reducing the activity of cortical interneurons, which particularly rely on NMDARs for their excitatory drive early in development 29,79 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [29]
In the citing paper
“Moreover, and as a result, PVI function itself might be permanently impaired as a result of relatively mild transient NMDAR hypofunction in the developing mouse that does not induce neuronal death 29,80 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [29]
In the citing paper
“The mechanism underlying this proposed loss of PVI phenotype involves cortical disinhibition leading to neuronal IL-6 production and consequent activation of NADPH oxidase, which generates H 2 O 2 29 .”
From Linking early-life NMDAR hypofunction and oxidative stress in schizophrenia pathogenesis (2016) · cites this paper as [29]
Citations
Cites
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
Krystal, J. H. (1994) · Archives of General Psychiatry · doi:10.1001/archpsyc.1994.03950030035004 · Cited by 3,330
Recent advances in the phencyclidine model of schizophrenia
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.10.1301 · Cited by 2,904
Gazzaniga, M. S., & Bizzi, E. (2000) · Cited by 2,547
Effects of Different Brain Lesions on Card Sorting: The Role of the Frontal Lobes
MILNER, B. (1963) · Archives of Neurology · doi:10.1001/archneur.1963.00460070100010 · Cited by 2,217
Blockade of NMDA Receptors and Apoptotic Neurodegeneration in the Developing Brain
Ikonomidou, C., Bosch, F., Miksa, M., Bittigau, P., Vöckler, J., Dikranian, K., Tenkova, T. I., Stefovska, V., Turski, L., & Olney, J. W. (1999) · Science · doi:10.1126/science.283.5398.70 · Cited by 2,055
Translating developmental time across mammalian species
Clancy, B., Darlington, R. B., & Finlay, B. L. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00171-3 · Cited by 1,221
Genes for schizophrenia? Recent findings and their pathophysiological implications
Harrison, P. J., & Owen, M. J. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12379-3 · Cited by 597
Glutamatergic mechanisms in schizophrenia
Tsai, G., & Coyle, J. T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.082701.160735 · Cited by 577
Bringing Order to the Glutamate Chaos in Schizophrenia
Moghaddam, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00757-8 · Cited by 403
Self-citation
Cited by
Sorted by citations
Items 101–157 of 157
du Bois, T. M., Newell, K. A., Han, M., Deng, C., & Huang, X. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.10.001 · Cited by 19
Schiavone, S., Morgese, M. G., Bové, M., Colia, A. L., Maffione, A. B., Tucci, P., Trabace, L., & Cuomo, V. (2019) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2019.109750 · Cited by 19
Zhan, J., Chen, C., Wu, S., Wu, H., Zou, K., Xiong, J., Wei, B., & Yang, Y. (2021) · Journal of Neurochemistry · doi:10.1111/jnc.15370 · Cited by 19
Plataki, M. E., Diskos, K., Sougklakos, C., Velissariou, M., Georgilis, A., Stavroulaki, V., & Sidiropoulou, K. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2021.689193 · Cited by 20
Pradhan, G., Melugin, P. R., Wu, F., Fang, H. M., Weber, R. E., & Kroener, S. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4900-1 · Cited by 21
Uehara, T., Sumiyoshi, T., & Kurachi, M. (2015) · Current Neuropharmacology · doi:10.2174/1570159x13666151009120153 · Cited by 18
Chohan, T. W., Nguyen, A. P., Todd, S. M., Bennett, M. R., Callaghan, P. D., & Arnold, J. C. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00298 · Cited by 17
Kim, S. H., Park, H. G., Kim, H. S., Ahn, Y., & Kim, Y. S. (2010) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991192 · Cited by 15
Contribution of K+–Cl− cotransporter 2 in MK-801-induced impairment of long term potentiation
Liu, Y. H., Chen, J., Song, T., Hu, C., Tang, Y., Zhang, X., & Zhao, J. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.02.028 · Cited by 15
Hernández‐Frausto, M., López‐Rubalcava, C., & Galván, E. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.01.036 · Cited by 15
Cortez, I. L., da Silva, N. R., Rodrigues, N. S., Pedrazzi, J. F. C., Bel, E. A. D., Mechoulam, R., Gomes, F. V., & Guimarães, F. S. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110553 · Cited by 15
Uehara, T., Itoh, H., Matsuoka, T., Rujescu, D., Genius, J., Seo, T., & Sumiyoshi, T. (2011) · Synapse · doi:10.1002/syn.21529 · Cited by 15
Dizocilpine reduces head diameter of dendritic spines in the hippocampus of adolescent rats
Han, D., Xu, L., Xiao, H., Schmidt, G. C. P., & Shi, S. (2013) · Psychiatry Research · doi:10.1016/j.psychres.2013.04.025 · Cited by 15
Marmolejo, N., Paez, J., Levitt, J. B., & Jones, L. B. (2012) · Developmental Neuroscience · doi:10.1159/000343911 · Cited by 14
Rapanelli, M., Frick, L. R., Bernardez-Vidal, M., & Zanutto, B. S. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.09.043 · Cited by 14
Kawabe, K. (2017) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2017.06.009 · Cited by 14
Phensy, A. J., Lindquist, K. L., Lindquist, K. A., Bairuty, D., Gauba, E., Guo, L., Tian, J., Du, H., & Kroener, S. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0880-20.2020 · Cited by 13
Ericek, O. B., Akıllıoğlu, K., Şaker, D., Cevik, I., Kutlu, M. D., Kara, S., & Yılmaz, D. M. (2022) · Ultrastructural Pathology · doi:10.1080/01913123.2021.2024633 · Cited by 12
Park, S. J., Jeon, S. J., Peña, I. D., Lee, H. E., Kim, D. H., Kim, J., Lee, Y. W., Jung, J. M., Shin, B. Y., Lee, S., et al. (2013) · Phytotherapy Research · doi:10.1002/ptr.4929 · Cited by 10
Kocahan, S., & Akıllıoğlu, K. (2013) · Neurochemical Research · doi:10.1007/s11064-013-1051-y · Cited by 10
Furuie, H., Yamada, K., & Ichitani, Y. (2019) · Brain Research · doi:10.1016/j.brainres.2019.146339 · Cited by 9
Niikura, R., Nozawa, T., Yamada, K., Kato, K., & Ichitani, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.01.029 · Cited by 9
Cortical and thalamic modulation of auditory gating in the posterior parietal cortex of awake mice
Wang, S., Li, Z., Wang, X., Li, J., Wang, X., Chen, J., Li, Y., Wang, C., & Qin, L. (2023) · Cerebral Cortex · doi:10.1093/cercor/bhac539 · Cited by 7
Büki, A., Bohár, Z., Kékesi, G., Vécsei, L., & Horváth, G. (2021) · Physiology & Behavior · doi:10.1016/j.physbeh.2021.113651 · Cited by 7
Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia
Gawai, P., Upadhyay, R., Gakare, S. G., Sarode, L. P., Dravid, S. M., & Ugale, R. R. (2019) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000532 · Cited by 7
Furuie, H., Yamada, K., & Ichitani, Y. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2015.12.044 · Cited by 6
Kawabe, K., & Miyamoto, E. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.111926 · Cited by 6
Schizophrenia in the 21st Century
Burne, T. H. J. (2012) · InTech eBooks · doi:10.5772/1669 · Cited by 5
Neuropathological Background of MK-801 for Inducing Murine Model of Schizophrenia
Murueta‐Goyena, A., Odrioizola, A. B., Gargiulo, P. Á., & Lafuente, J. V. (2017) · Springer eBooks · doi:10.1007/978-3-319-53126-7_25 · Cited by 3
The impact of social isolation on rat behaviour
Porkess, V. (2008) · Nottingham ePrints (University of Nottingham) · Cited by 3
Modulation of neuronal morphology by antipsychotic drug: Involvement of serotonin receptor 7
Speranza, L., Molinari, M., Volpicelli, F., Lacivita, E., Leopoldo, M., Pulcrano, S., Bellenchi, G. C., Perrone‐Capano, C., & Crispino, M. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148815 · Cited by 2
Serotonin-1A Receptors and Cognitive Enhancement in Schizophrenia: Role for Brain Energy Metabolism
Sumiyoshi, T., & Uehar, T. (2012) · InTech eBooks · doi:10.5772/36118 · Cited by 2
Glutamatergic Neurotransmission Abnormalities and Schizophrenia
Dwivedi, Y., & Pandey, G. N. (2011) · Springer eBooks · doi:10.1007/978-94-007-0837-2_13 · Cited by 2
Glutamatergic Synaptic Dysregulation in Schizophrenia
Coyle, J. T., Basu, A. C., & Benneyworth, M. A. (2012) · Wiley eBooks · doi:10.1002/9781118309421.ch5 · Cited by 2
Kielhold, M. L., Jacobs, D. S., Pacheco, A. T., Lefner, M. J., Bogachuk, A. P., Lebowitz, J. J., Langdon, A. J., Williams, J. T., Zweifel, L., & Moghaddam, B. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03632-1 · Cited by 1
Self-citationChen, W., & Johnston, I. N. (2026) · Behavioural Brain Research · doi:10.1016/j.bbr.2026.116331 · Cited by 1
Liu, H., Ren, Z., Zhong, J. Q., Cai, H., Chen, X., & Li, J. (2014) · International Journal of Pharmacology · doi:10.3923/ijp.2014.120.128 · Cited by 1
Toyoshima, M., Takahashi, K., Sato, E., Shimoda, S., & Yamada, K. (2024) · Behavioural Brain Research · doi:10.1016/j.bbr.2024.115276 · Cited by 1
Gallant, S. (2014) · Spectrum Research Repository (Concordia University)
Jafari, S. (2012) · Research Online (University of Wollongong)
Brown, M. A., Bishnoi, R. J., Dholakia, S., & Velligan, D. I. (2015) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2016.1135734
Gomes, F. V. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2016.tde-05012016-224242
Akıllıoğlu, K., Melik, E. B., & Melik, E. (2012) · Erciyes Medical Journal · doi:10.5152/etd.2012.13
Sigma-1 Receptor (σ – 1R) Activation and Modulation of NMDA Receptor Surface Expression
Hristova, E. (2014) · uO Research (University of Ottawa) · doi:10.20381/ruor-6671
da Silva, N. R. (2017) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.17.2017.tde-22082017-144713
Coleman, L. G. (2010) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/ddyv-cr38
Gray, S. W. (2020) · Digital Commons - Colby (Colby College)
da Silva, N. R. (2021) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2021.tde-05112021-105109
(2005) · Biological Psychiatry · doi:10.1016/s0006-3223(05)00639-6
Mueller, D., Knep, E., Velosa, A., Giglio, E., Chen, C. S., Heilbronner, S. R., Ebitz, R. B., Rothwell, P. E., & Grissom, N. M. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.06.28.662127
In utero exposure to NMDA receptor autoantibodies disrupts hippocampal circuit maturation
Majoros, M., Zhang, C., Rahmati, V., Graf, J., Heckmann, M., Geis, C., Kreye, J., Kaindl, A. M., Prüß, H., Holthoff, K., et al. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117022 · Cited by 1
Lagamjis, G., Slayton, D., Lu, H., Hoerner, C., Lantry, A. M., Marion, M., Elman, D. J., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2026) · Neurochemical Research · doi:10.1007/s11064-026-04743-5
Zhan, J., Li, Y., Jiang, F.-H., Wang, H., Huang, Y., Zhan, H.-Y., Xu, X., Liao, D., Zhang, J., Chen, L., et al. (2026) · Journal of Neurochemistry · doi:10.1111/jnc.70456
Mueller, D., Knep, E., Velosa, A., Giglio, E., Chen, C. S., Heilbronner, S. R., Ebitz, R. B., Rothwell, P. E., & Grissom, N. M. (2026) · Psychopharmacology · doi:10.1007/s00213-026-07081-0 · Cited by 2
Metadata
- Authors
- Stefani, M. R., & Moghaddam, B.
- Affiliations
- University of Pittsburgh (US)
- Corresponding author
- Stefani, Mark Renato
- ORCID
- Moghaddam, Bita
- Venue
- Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2005-02
- Volume
- 57
- Issue
- 4
- Pages
- 433-436
- ISSN
- 0006-3223 (ISSN-L)
- OpenAlex
- W1983202833
- Cited by
- 157
- References
- 32
- Citations by year
- 2026: 6 · 2025: 1 · 2024: 2 · 2023: 2 · 2022: 2 · 2021: 7 · 2020: 2 · 2019: 13 · 2018: 3 · 2017: 6 · 2016: 4 · 2015: 12 · 2014: 9 · 2013: 15 · 2012: 16
- FWCI
- 5.41
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Mental Health (R21 MH65026, K02 MH01616, K02MH001616, R37MH048404, R37-MH48404, R21MH065026)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- NMDA receptor, MK-801, schizophrenia, cognitive flexibility, working memory, perseveration, glutamatergic neurotransmission, postnatal development, cortical development, cognitive impairment, rat model
- MeSH terms
- Age Factors, Animals, Animals, Newborn, Behavior, Animal, Cognition Disorders, Discrimination, Psychological, Exploratory Behavior, Locomotion, Male, Memory, Short-Term, Neuropsychological Tests, Psychomotor Performance, Schizophrenia, Receptors, N-Methyl-D-Aspartate, Dizocilpine Maleate, Rats, Sprague-Dawley, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review